The ion channels in the membrane of vascular smooth muscle cells play an important role in excitation-contraction coupling and in setting vasomotor tone. The activity of these ion channels is controlled by neurotransmitters such as norepinephrine, vasoactive hormones such as angiotensin-II, an clinically useful drugs such as Ca2+ antagonists. The ion channels may be regulated either directly or indirectly by these substances, and the regulatory processes may include the formation or release of intracellular messengers, such as Ca2+, ATP, G-proteins, cyclic AMP, cyclic GMP, inositol phosphates (IP3/IP4), and diacylglycerol. In some disease states, the properties and/or regulation of the ion channels may be altered. Since blood vessels from different regions have different degrees of excitability,k the proportion of various ion channels and/or their regulatory processes may differ also. The objective of this study is to investigate in detail the specific characteristics and regulatory mechanisms for the ion channels, including the various types of Ca2+ and K+ channels, in freshly isolated and cultured vascular smooth muscle cells. Macroscopic and microscopic (single-channel) currents will be recorded using whole-cell voltage clamp and patch-clamp techniques, respectively. The influence of intracellular levels of Ca2+, ATP, and cyclic nucleoties on the activity of Ca2+ and K+ channels will be determined by intracellular perfusion of these substances. A possible role of phosphorylation mediated by various protein kinases (i.e., cyclic nucleotide-dependent, Ca2+/calmodulin-dependent, and Ca2+/phospholipid-dependent) in regulating ion channel activity and cellular excitability will be explored. The mechanism of action of vasoactive substances will be investigated. The possible role of phosphoinositide metabolism (i.e., IP3, IP4, and diacyclglycerol formation) in the electrophysiological actions of agonists such as angiotensin-II will be assessed. The possible gating of ion channels by G-proteins will also be investigated. The results of these studies should provide comprehensive information about how ion channels in vascular smooth muscle function and are regulated and should help to clarify how cellular excitability is altered by important vasoactive substances.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL040572-01A3
Application #
3357830
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Project Start
1990-07-01
Project End
1993-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
1
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Cincinnati
Department
Type
Schools of Medicine
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Sunagawa, M; Nakamura, M; Kosugi, T et al. (2001) Lack of tyrosine protein kinase regulation of L-type Ca2+ channel current in transfected cells stably expressing alpha1C-b Subunit. Jpn J Physiol 51:115-9
Nakamura, M; Sunagawa, M; Kosugi, T et al. (2000) Actin filament disruption inhibits L-type Ca(2+) channel current in cultured vascular smooth muscle cells. Am J Physiol Cell Physiol 279:C480-7
Yokoshiki, H; Seki, T; Sunagawa, M et al. (2000) Inhibition of Ca2+-activated K+ channels by tyrosine phosphatase inhibitors in rat mesenteric artery. Can J Physiol Pharmacol 78:745-50
Yokoshiki, H; Sunagawa, M; Seki, T et al. (1999) Antisense oligodeoxynucleotides of sulfonylurea receptors inhibit ATP-sensitive K+ channels in cultured neonatal rat ventricular cells. Pflugers Arch 437:400-8
Sunagawa, M; Yokoshiki, H; Seki, T et al. (1999) Direct block of Ca2+ channels by calmidazolium in cultured vascular smooth muscle cells. J Cardiovasc Pharmacol 34:488-96
Seki, T; Yokoshiki, H; Sunagawa, M et al. (1999) Angiotensin II stimulation of Ca2+-channel current in vascular smooth muscle cells is inhibited by lavendustin-A and LY-294002. Pflugers Arch 437:317-23
Katsube, Y; Yokoshiki, H; Sunagawa, M et al. (1998) Carbachol inhibition of Ca2+ currents in ventricular cells obtained from neonatal and adult rats. Eur J Pharmacol 358:269-75
Katsube, Y; Yokoshiki, H; Nguyen, L et al. (1998) L-type Ca2+ currents in ventricular myocytes from neonatal and adult rats. Can J Physiol Pharmacol 76:873-81
Sunagawa, M; Yokoshiki, H; Seki, T et al. (1998) Intracellular application of calmidazolium increases Ca2+ current through activation of protein kinase A in cultured vascular smooth muscle cells. J Vasc Res 35:303-9
Yokoshiki, H; Katsube, Y; Sunugawa, M et al. (1997) Disruption of actin cytoskeleton attenuates sulfonylurea inhibition of cardiac ATP-sensitive K+ channels. Pflugers Arch 434:203-5

Showing the most recent 10 out of 23 publications